bpc-157 periodontal regeneration study An older but it basically states what many of us know about peptides. treatment showed potent anti-inflammatory effects on tissues and significantly reduced alveolar bone loss compared to controls Recent advances in periodontal regeneration:

Collateralization and Vascular Growth BPC 157 is an effective angiogenic factor that enhances endothelial cell proliferation and growth

P.ReddyP

Injection into sensitive or low-fat tissue: Areas such as the abdomen, inner thigh, or other sites with minimal subcutaneous fat have less tissue cushioning and a higher density of sensory nerve endings, making pH-related discomfort more noticeable

Demonstrates anti-inflammatory and cytoprotective properties in preclinical settings [6]

Use a fresh needle for each injection to minimize bacterial contamination and maintain a consistent seal

FDA Regulatory Status The FDAs position is unambiguous: BPC-157 is not an approved drug for any medical condition